Dr. Aditya Kelkar

Director, National Institute of Ophthalmology, Pune.

1 article

Dr Aditya Kelkar MS; DNB; FRCS; FACS is the Director, National Institute of Ophthalmology, Pune. He has published more than 30 papers in peer reviewed indexed journals and invited at various national and international conferences as a guest speaker. He is the recipient of the prestigious IJO gold award, best paper at Asia Pacific academy of ophthalmology and intraocular implant and refractive society.

  1. Articles 1 Apr 2021 18 min read

    Proliferative Diabetic Retinopathy

    Diabetic retinopathy (DR) is the leading cause of visual impairment worldwide. It almost accounts for 2.6% of treatable blindness globally (1). It is estimated that the overall prevalence of diabetic retinopathy is 34.6 % worldwide, while the prevalence of proliferative diabetic retinopathy (PDR) is 6.96% and that of vision-threatening DR (VTDR) is computed to be 10.2% (2). Currently, the prevalence of PDR in India is estimated to be 17% which is significantly higher compared to patients from other locations of Asia (3). Early detection and treatment is the only key to avoiding complications and risks of vision loss (4). But the major obstacle ahead of us in India is the failure to diagnose DR in early stages; as it is observed that only 18–35% of diabetics undergo ophthalmologic evaluation regularly (5). Pathogenesis Diabetic retinopathy is recognized as a neuro-vascular complication of diabetes. The triad of hyperglycemia, inflammation, and hypoxia along with retinal neurodegeneratio

    Dr. Aditya Kelkar · Dr. Mounika Bolisetty